Shire Changes its NASDAQ Ticker Symbol to SHPG
DUBLIN, Ireland, July 9, 2012 /PRNewswire/ –
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical
company, announces that the NASDAQ ticker symbol for Shire’s American Depositary Shares
(“ADSs”) will change from “SHPGY” to “SHPG” on and from the opening of NASDAQ trading on
July 11, 2012.
Each ADS continues to represent 3 ordinary shares of Shire plc.
The London Stock Exchange ticker symbol for Shire plc’s ordinary shares remains “SHP”.
Notes to editors
Shire’s strategic goal is to become the leading specialty biopharmaceutical company
that focuses on meeting the needs of the specialist physician. Shire focuses its business
on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal
diseases and regenerative medicine as well as opportunities in other therapeutic areas to
the extent they arise through acquisitions. Shire’s in-licensing, merger and acquisition
efforts are focused on products in specialist markets with strong intellectual property
protection and global rights. Shire believes that a carefully selected and balanced
portfolio of products with strategically aligned and relatively small-scale sales forces
will deliver strong results.
For further information on Shire, please visit the Company’s website:
For further information please contact:
Investor Relations Eric Rojas email@example.com +1-781-482-0999 Sarah Elton-Farr firstname.lastname@example.org +44(0)1256-894157
SOURCE Shire plc